Trial of Homocysteine Reduction In the prevention of Vascular Events and Dementia in the elderly

ISRCTN ISRCTN07337345
DOI https://doi.org/10.1186/ISRCTN07337345
Protocol serial number 112/57
Sponsor The Health Foundation (UK)
Funder The Health Foundation (UK)
Submission date
12/09/2002
Registration date
12/09/2002
Last edited
05/01/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr David J Stott
Scientific

Academic Section of Geriatric Medicine
3rd Floor Centre Block
Glasgow Royal Infirmary
Glasgow
G4 0SF
United Kingdom

Phone +44 (0)141 211 4976
Email d.j.stott@clinmed.gla.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymTHRIVED
Study objectives1. What are the effects of vitamin combinations (comprising of folic acid plus B12, B6 and B2, each alone and in combination) on serum homocysteine (HCY) in elderly patients with vascular disease?
2. Is telephone follow-up of cognitive function and of disability practicable in this cohort of patients?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedIschaemic vascular disease
InterventionPatients will receive vitamin folic acid (2 mg) plus vitamin B12 (400 mg) or placebo, vitamin B6 (25 mg) or placebo, and B2 (25 mg), in a factorial 2 by 2 design.
Intervention typeSupplement
Primary outcome measure(s)

1. Serum HCY, plasma von Willebrand factor, vitamin levels (red cell folate, serum vitamin B12, B2 and B6)
2. Piloting of telephone follow-up of cognition (Telephone Interview for Cognitive Status [TICSm]) and of disability (Barthel Index and short Instrumental Activities for Daily Living [ADL] scale)

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/11/2003

Eligibility

Participant type(s)Patient
Age groupSenior
SexNot Specified
Target sample size at registration100
Key inclusion criteria1. Age greater than 65 years
2. Ischaemic vascular disease (at least one of the following: history of angina pectoris, acute myocardial infarction, evidence of major ischaemia or previous infarction on 12-lead electrocardiogram, ischaemic stroke, transient ischaemic attack, intermittent claudication, previous surgery for ischaemic vascular disease)
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/12/2001
Date of final enrolment30/11/2003

Locations

Countries of recruitment

  • United Kingdom
  • Scotland

Study participating centre

Academic Section of Geriatric Medicine
Glasgow
G4 0SF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2005 Yes No